Co-Diagnostics, Inc. (CODX) vs Ensysce Biosciences, Inc. (ENSC)
A side-by-side comparison of Co-Diagnostics, Inc. and Ensysce Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CODX
Co-Diagnostics, Inc.
$1.10HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ENSC
Ensysce Biosciences, Inc.
$0.42HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CODX vs ENSC
growth of $100 · dividends reinvested · last 9yCODX -98.4% (-36.7%/yr)ENSC -100.0% (-71.6%/yr)CODX compounded faster over this window
Log scale — wide-divergence pair
CODX ENSC
CODX vs ENSC: by the numbers
- •CODX is the larger company ($7M vs $6M market cap).
- •Both run net losses; ENSC's is the smaller (-1084.23% vs -6523.04% net margin).
Metrics side by side
Valuation
| Metric | CODX | ENSC |
|---|---|---|
| P/S ratio | 9.53 | 5.53 |
| P/B ratio | 0.54 | N/A |
Profitability
| Metric | CODX | ENSC |
|---|---|---|
| Gross margin | 64.28% | 0.00% |
| Operating margin | -5025.53% | 0.00% |
| Net margin | -6523.04% | -1084.23% |
| ROE | -370.16% | N/A |
| ROIC | -219.15% | N/A |
Growth (annualized)
| Metric | CODX | ENSC |
|---|---|---|
| Revenue CAGR (5Y) | -62.43% | N/A |
| Total return CAGR (5Y) | -66.53% | -86.22% |
Frequently asked
- How have CODX and ENSC total returns compared?
- Over the past 5 years, CODX delivered -66.53% and ENSC delivered -86.22% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.